Task: Answer the multiple-choice question.
Query: Which compound exhibits a 2.201% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a COc1ccc(S(=O)(=O)Nc2nc3c(s2)CCCC3)cc1
b COCCNc1c2c(nc3c(-c4ccccc4)c(C)nn13)CCC2
c O=C(Cn1c(=O)oc2ccccc21)Nc1ccc(F)cc1
Answer: b. COCCNc1c2c(nc3c(-c4ccccc4)c(C)nn13)CCC2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COCCNc1c2c(nc3c(-c4ccccc4)c(C)nn13)CCC2
COCCNc1c2c(nc3c(-c4ccccc4)c(C)nn13)CCC2
N-(2-methoxyethyl)-11-methyl-10-phenyl-1,8,12-triazatricyclo[7.3.0.03,7]dodeca-2,7,9,11-tetraen-2-amine